Sign In

Login

Password

Forgot Password ? Sign Up

Regdanvimab (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Regdanvimab" in French language version.

refsWebsite
Global rank French rank
1issn.org
57th place
4th place
1nih.gov
4th place
12th place
1doi.org
2nd place
3rd place
1oup.com
485th place
416th place
1mfds.go.kr
low place
low place
1lunion.fr
low place
705th place

doi.org (Global: 2nd place; French: 3rd place)

dx.doi.org

  • (en) Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu et Jin Yong Kim, « Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019 », Open Forum Infectious Diseases, vol. 9, no 4,‎ (ISSN 2328-8957, PMID 35295819, PMCID 8903348, DOI 10.1093/ofid/ofac053, lire en ligne, consulté le )

issn.org (Global: 57th place; French: 4th place)

portal.issn.org

  • (en) Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu et Jin Yong Kim, « Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019 », Open Forum Infectious Diseases, vol. 9, no 4,‎ (ISSN 2328-8957, PMID 35295819, PMCID 8903348, DOI 10.1093/ofid/ofac053, lire en ligne, consulté le )

lunion.fr (Global: low place; French: 705th place)

mfds.go.kr (Global: low place; French: low place)

nih.gov (Global: 4th place; French: 12th place)

ncbi.nlm.nih.gov

  • (en) Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu et Jin Yong Kim, « Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019 », Open Forum Infectious Diseases, vol. 9, no 4,‎ (ISSN 2328-8957, PMID 35295819, PMCID 8903348, DOI 10.1093/ofid/ofac053, lire en ligne, consulté le )

oup.com (Global: 485th place; French: 416th place)

academic.oup.com

  • (en) Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu et Jin Yong Kim, « Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019 », Open Forum Infectious Diseases, vol. 9, no 4,‎ (ISSN 2328-8957, PMID 35295819, PMCID 8903348, DOI 10.1093/ofid/ofac053, lire en ligne, consulté le )